These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22664224)

  • 1. Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance.
    Petousis-Harris H; Poole T; Turner N; Reynolds G
    Vaccine; 2012 Jul; 30(33):4945-52. PubMed ID: 22664224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactogenicity of two 2010 trivalent inactivated influenza vaccine formulations in adults.
    Leeb A; Carcione D; Richmond PC; Jacoby P; Effler PV
    Vaccine; 2011 Oct; 29(45):7920-4. PubMed ID: 21864621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fever following administration of two inactivated influenza vaccines--a survey of parents of New Zealand infants and children 5 years of age and under.
    Petousis-Harris H; Poole T; Booy R; Turner N
    Vaccine; 2011 Apr; 29(16):2933-7. PubMed ID: 21338679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms.
    Blyth CC; Currie AJ; Wiertsema SP; Conway N; Kirkham LA; Fuery A; Mascaro F; Geelhoed GC; Richmond PC
    Vaccine; 2011 Jul; 29(32):5107-13. PubMed ID: 21640152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States during 2010-11.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Aug; 59(31):989-92. PubMed ID: 20703207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study.
    Stowe J; Andrews N; Bryan P; Seabroke S; Miller E
    Vaccine; 2011 Nov; 29(51):9467-72. PubMed ID: 22019757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.
    Tse A; Tseng HF; Greene SK; Vellozzi C; Lee GM;
    Vaccine; 2012 Mar; 30(11):2024-31. PubMed ID: 22361304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events.
    Dey A; Gidding HF; Menzies R; McIntyre P
    Vaccine; 2014 Apr; 32(19):2204-8. PubMed ID: 24613527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
    McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
    Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of fever following one dose of trivalent inactivated influenza vaccine in children aged ≥6 months to <36 months: a comparison of published and unpublished studies.
    Kaczmarek MC; Duong UT; Ware RS; Lambert SB; Kelly HA
    Vaccine; 2013 Nov; 31(46):5359-65. PubMed ID: 24055353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual report: surveillance of adverse events following immunisation in Australia, 2010.
    Mahajan D; Cook J; McIntyre PB; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2011 Dec; 35(4):263-80. PubMed ID: 22624487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active SMS-based influenza vaccine safety surveillance in Australian children.
    Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
    Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink.
    Glanz JM; Newcomer SR; Hambidge SJ; Daley MF; Narwaney KJ; Xu S; Lee GM; Baggs J; Klein NP; Nordin JD; Naleway AL; Belongia EA; Weintraub ES
    Arch Pediatr Adolesc Med; 2011 Aug; 165(8):749-55. PubMed ID: 21810637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccine safety in children less than 5 years old: the 2010 and 2011 experience in Australia.
    Wood N; Sheppeard V; Cashman P; Palasanthiran P; Casacelli M; Cannings K; McIntyre P
    Pediatr Infect Dis J; 2012 Feb; 31(2):199-202. PubMed ID: 22094632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age.
    Baxter R; Toback SL; Sifakis F; Hansen J; Bartlett J; Aukes L; Lewis N; Wu X; Ambrose CS
    Vaccine; 2012 Apr; 30(19):2989-98. PubMed ID: 22386746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.
    Vesikari T; Karvonen A; Smith HM; Dunning A; Razmpour A; Saville MK; Gruber WC; Forrest BD
    Pediatrics; 2008 Mar; 121(3):e568-73. PubMed ID: 18299305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010.
    Moro PL; Arana J; Cano M; Menschik D; Yue X; Lewis P; Haber P; Martin D; Broder K
    Clin Infect Dis; 2012 Jun; 54(11):1608-14. PubMed ID: 22441652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children.
    Englund JA; Walter EB; Fairchok MP; Monto AS; Neuzil KM
    Pediatrics; 2005 Apr; 115(4):1039-47. PubMed ID: 15805382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.